FDA Grants Priority Review to Genentech's Baloxavir Marboxil for the Treatment of Influenza

[Anonymous]

CLINICAL INFECTIOUS DISEASES, 2018; 67 (7): I

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索